Gumilid, Romeo D.
HRN: 22-55-79 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2024
CEFTRIAXONE 1G (VIAL)
10/16/2024
10/22/2024
IVT
2g
OD
Bilateral Pleural Effusion Sec To Parapneumonic Process
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes